Oriva

Gesynta

This pharmaceutical company develops non-hormonal oral treatments targeting chronic inflammation and pain for patients with endometriosis and other inflammatory conditions.

Gesynta Pharma

This company develops anti-inflammatory and pain-relieving oral pharmaceuticals targeting the mPGES-1 enzyme for patients with endometriosis and chronic inflammatory conditions.

Metri

This biotechnology company develops organoid-based human models to create therapeutics for patients with uterine and endometrial diseases.

Antiva Biosciences

This company develops topical antiviral treatments for high-risk human papillomavirus infections and pre-cancerous cervical lesions in women.

Madorra

This medical device company develops a non-hormonal, non-invasive treatment for vaginal dryness in post-menopausal people and breast cancer survivors.

Tium Bio

This biopharmaceutical company develops therapeutics for rare and incurable diseases, including treatments for endometriosis, uterine fibroids, hemophilia and various cancers.

Afynia

This company develops non-invasive blood tests to diagnose endometriosis for women and fertility clinics.

UTERINE FIBROID TREATMENT

This medical technology company develops a minimally invasive, uterus-sparing radiofrequency ablation system for women suffering from symptomatic uterine fibroids.